Neoplasia/BPH

	Outcomes of Free Flap Surgery in Head and Neck Cancer Patients With Chronic Kidney Disease: A Single-Institution Retrospective Study of 61 Cases. Cureus Nagano K, Osaki M, Kuba K, Hatanaka A, Hara M, Manaka K, Kinoshita S, Mitsumura K, Mukae R, Ohtake E. PMID: 41523460 [PubMed - as supplied by publisher]
	Focal irreversible electroporation for the treatment of localised prostate cancer: a systematic review. Transl Androl Urol Cheng J, Adhami M, King D, Yaxley J, Kavnoudias H, Grummet J. PMID: 41522319 [PubMed]
	Immunohistochemical study of Rho-kinase pathway expression in a mouse model of prostate hypertrophy for preliminary study of progressive prostate cancer model establishment. Transl Androl Urol Yang YM, Kitagawa K, Hirata Y, Moriwaki M, Ono T, Chiang YT, Chen KC, Shigemura K. PMID: 41522316 [PubMed]
	Knowledge, attitudes, and practices regarding prostate cancer and early screening among middle-aged and elderly Chinese men: a cross-sectional study. Transl Androl Urol Tang S, Wang J, Xu J, Shen J. PMID: 41522314 [PubMed - in process]
	Diagnostic performance of gastrin-releasing peptide receptor-targeted positron-emission tomography in biochemically recurrent prostate cancer-a systematic review and meta-analysis. Quant Imaging Med Surg Huang H, Huang Y, Xie Z, Tian R, Shen G. PMID: 41522030 [PubMed]
	Retrospective Analysis of Vesicourethral-Anastomosis Stricture/Urethral Stricture After Robotic-Assisted Laparoscopic Radical Prostatectomy With and Without Radiotherapy. Int J Urol Massouh K, Leucht K, Leistritz L, Grimm MO. PMID: 41521473 [PubMed - indexed for MEDLINE]
	Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study. World J Urol Scilipoti P, Zaurito P, Longoni M, Tremolada G, Cosenza A, , Gabriel PE, Dutto D, Katzendorn O, Krajewski W, Laukhtina E, Oberneder K, Elena JLR, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Subiela JD, Fernández A, Marcq G, Szostek A, Mastroianni R, Simone G, Pichler R, Álvarez-Maestro M, Bazán AA, Klatte T, du Biest AM, Ferrando V, Buisan O, López AV, Zazzara M, Ludovico GM, Carando R, Radziszewski P, Soria F, Pradere B, D'Andrea D, Shariat SF, Montorsi F, Salonia A, Briganti A, Gontero P, Xylinas E, Moschini M, European Association of Urology -Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group, EuroGemDoce Study Group Collaborators. PMID: 41521375 [PubMed - in process]
	Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer. Cancer Med Faraj KS, Oerline M, Kaufman SR, Dall C, Srivastava A, Liu X, Caram MEV, Shahinian VB, Hollenbeck BK. PMID: 41521275 [PubMed - indexed for MEDLINE]
	Theranostic Nanoparticles in Prostate Cancer: Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites. Cancer Med Uti DE, Omang WA, Alum EU, Bawa I, Ugwu OP, Idowu AO, Atangwho IJ, Egbung GE. PMID: 41521160 [PubMed - indexed for MEDLINE]
	The Performance of MR Cytometry Imaging in Differentiating High- and Low-Grade Bladder Cancer. J Magn Reson Imaging Chen L, Jin C, Guo E, Liu F, Wang Y, Zhu J, Zhang X, Zhang J, Xu Z, Bai X, Wu Y, Tan Z, Jiang X, Feiweier T, Jin Z, Xu J, Guo H, Zhang G, Xue H, Shi D, Sun H. PMID: 41521156 [PubMed - as supplied by publisher]
	Living with a Prostate Cancer Patient: Real-world Evidence from the Europa Uomo Prostate Cancer Partners in Europe Research Study. Eur Urol Oncol Venderbos LDF, Remmers S, Deschamps A, Boogh I, Estape T, Carl EG, Azevedo NP, Roobol MJ. PMID: 41521096 [PubMed - as supplied by publisher]
	Comparison of the Oncologic Outcomes of Cryoablation, Laser Ablation, and Hyperthermia for Localized Prostate Cancer: A Population-Based Cohort Study Using the SEER Database. Clin Genitourin Cancer Guo RQ, Sun J, Bie ZX, Li YM. PMID: 41521094 [PubMed - as supplied by publisher]
	The Role of Nutrition in Prostate Cancer Risk, Progression, and Mortality: A Comprehensive Review. Clin Nutr ESPEN Souroujon AA, Sundaresan V, Golos A, Leapman M, Gomez-Santamaría OA, Casilla-Lennon M. PMID: 41520878 [PubMed - as supplied by publisher]
	Molecular characterization of palmitoylation in prostate cancer reveals KIFC2 as a prognostic biomarker and potential therapeutic target. Comput Biol Med Huang L, Jiang S, Zeng F, Zeng G, Shan H. PMID: 41520472 [PubMed - as supplied by publisher]
	Comparative efficacy of hyperthermic chemotherapy and BCG instillation in non-muscle invasive bladder cancer: a systematic review and meta-analysis. Int Urol Nephrol Chai Y, Zhou Y, Peng H, Jiang Y, Dai J, Liu J. PMID: 41520313 [PubMed - as supplied by publisher]
	Feasibility and first-year findings of a pilot program of prostate cancer screening in Croatia (CROState). Croat Med J Ka, Kuli, Grubi, Brki, Prutki M, Buba, Capak K. PMID: 41520199 [PubMed - indexed for MEDLINE]
	Pre-diagnostic circulating untargeted metabolomics and risk of overall and clinically significant prostate cancer: a systematic review andÂ meta-analysis. Br J Cancer Fuller H, Agasaro OP, Guevara JM, Darst BF. PMID: 41520058 [PubMed - as supplied by publisher]
	Cross-omics interpretable neural network for discovery of molecular markers in prostate cancer. Comput Biol Chem Chen X, Yi S, Yuemaierabola A, Liu Y, He L, Ma J, Guo W, Sun G. PMID: 41518989 [PubMed - as supplied by publisher]
	Hereditary renal cell carcinoma surveillance protocols: a review of the literature and proposed recommendations. Fam Cancer Miranda M, Ferreira C, Fernandes M, Lopes F, Ye A, Sousa AB, Costa L, Palma Dos Reis J, Palmela Leitão T. PMID: 41518461 [PubMed - indexed for MEDLINE]
	Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests. Int J Cancer Huang Z, Yu L, Zhang X, Li Q, Liu S, Xu T. PMID: 41518076 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184597

Page 1 of 9230



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy